Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lefvert

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Tissue Antigens|February 1, 1997
TAP polymorphisms in Swedish myasthenia gravis patientsP Hjelmström, R Giscombe, A K Lefvert, et al.
Scandinavian Journal of Immunology|December 11, 2002
Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian childrenB Gyan, B Goka, J T Cvetkovic, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Effects of some immunosuppressive procedures on myasthenia gravisG Matell, K Bergström, C Franksson, et al.
Clinical and Experimental Immunology|February 1, 1997
A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritisS Nityanand, R Giscombe, S Srivastava, et al.
Molecular Medicine (Cambridge, Mass.)|July 1, 1996
Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?D Gigliotti, A K Lefvert, M Jeddi-Tehrani, et al.
Journal of Neuroimmunology|August 4, 1998
Polymorphism in tumor necrosis factor genes associated with myasthenia gravisP Hjelmström, C S Peacock, R Giscombe, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor regionP Hjelmström, C S Peacock, R Giscombe, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary reportR Pirkanen, K Bergström, L Hammarström, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibodyR Ahlberg, Q Yi, R Pirskanen, et al.
Acta Neurologica Scandinavica|December 1, 1986
Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodiesS Thorlacius, A K Lefvert, J A Aarli, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Tissue Antigens|February 1, 1997
TAP polymorphisms in Swedish myasthenia gravis patientsP Hjelmström, R Giscombe, A K Lefvert, et al.
Scandinavian Journal of Immunology|December 11, 2002
Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian childrenB Gyan, B Goka, J T Cvetkovic, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Effects of some immunosuppressive procedures on myasthenia gravisG Matell, K Bergström, C Franksson, et al.
Clinical and Experimental Immunology|February 1, 1997
A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritisS Nityanand, R Giscombe, S Srivastava, et al.
Molecular Medicine (Cambridge, Mass.)|July 1, 1996
Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?D Gigliotti, A K Lefvert, M Jeddi-Tehrani, et al.
Journal of Neuroimmunology|August 4, 1998
Polymorphism in tumor necrosis factor genes associated with myasthenia gravisP Hjelmström, C S Peacock, R Giscombe, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor regionP Hjelmström, C S Peacock, R Giscombe, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary reportR Pirkanen, K Bergström, L Hammarström, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibodyR Ahlberg, Q Yi, R Pirskanen, et al.
Acta Neurologica Scandinavica|December 1, 1986
Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodiesS Thorlacius, A K Lefvert, J A Aarli, et al.
Pageof 22